EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B

Mohammad Asadzadeh iD, Suhail Ahmad iD, Jacques F Meis iD, Josie E Parker iD, Wadha Alfouzan iD

Journal of Fungi · 30.07.2025 · 11 (8) · 570

DOI: 10.3390/jof11080570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 30.07.2025. Verfasst von Mohammad Asadzadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya 46300, Kuwait. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive infections with rare yeasts are increasing worldwide and are associated with higher mortality rates due to their resistance to antifungal drugs. Accurate antifungal susceptibility testing (AFST) is crucial for proper management of rare yeast infections. We performed AFST of 74 Candida kefyr isolates by Etest, EUCAST-based MICRONAUT-AM assay (MCN-AM) and reference Clinical and Laboratory Standards Institute broth microdilution method (CLSI). Essential agreement (EA, ±1 two-fold dilution), categorical agreement (CA), major errors (MEs) and very-major errors (VmEs) were determined using epidemiological cut-off values of ≤1.0 µg/mL, ≤0.03 µg/mL, ≤0.5 µg/mL and ≤1 µg/mL, defining wild-type isolates for fluconazole, voriconazole, micafungin and amphotericin B (AMB), respectively. Results for AMB susceptibility were correlated with ERG2/ERG3 mutations and total-cell sterols. CA of ≥97% was recorded between any two methods while EA varied between 72 and 82%, 87 and 92%, and 49 and 76% for fluconazole, voriconazole and micafungin, respectively. For AMB, CAs between CLSI and Etest; CLSI and MCN-AM; MCN-AM and Etest were 95% (4 ME, 0 VmE), 96% (3 ME, 0 VmE) and 99%, respectively, while EA varied from 32% to 69%. Non-synonymous ERG2/ERG3 mutations and no ergosterol were found in seven of eight isolates of non-wild types for AMB by Etest. Our data show that Etest, CLSI and MCN-AM methods are suitable for AFST of C. kefyr for fluconazole, voriconazole and micafungin. Excellent CAs for AMB between Etest and MCN-AM with concordant sterol profiles but not with CLSI suggest that Etest is also an excellent alternative for the detection of C. kefyr isolates with reduced susceptibility to AMB.

Schlagwörter

Stichwörter der Autor:innen

Candida kefyrEtestMICRONAUT-AM assayantifungal susceptibility testingcomparative performancereference CLSI method

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya 46300, Kuwait.
  • Department of Medical Microbiology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands.
  • Center of Expertise in Mycology Radboudumc/Canisius Wilhelmina Hospital, 6532 Nijmegen, The Netherlands.
  • Department I of Internal Medicine and Excellence Center for Medical Mycology, Faculty of Medicine, University Hospital Cologne, 50937 Cologne, Germany.
  • Molecular Biosciences Division, School of Biosciences, Cardiff University, Cardiff CF10 3AT, UK.

ORCID-Profile: Mohammad Asadzadeh, Suhail Ahmad, Jacques F Meis, Josie E Parker, Wadha Alfouzan

Zitieren

APA

Asadzadeh, M., Ahmad, S., Meis, J. F., Parker, J. E., & Alfouzan, W. (2025). Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B. Journal of Fungi, 11(8), 570. https://doi.org/10.3390/jof11080570

Vancouver

Asadzadeh M, Ahmad S, Meis JF, Parker JE, Alfouzan W. Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B. Journal of Fungi. 2025;11(8):570. doi:10.3390/jof11080570

BibTeX
@article{Asadzadeh2025,
  author = {Asadzadeh, Mohammad and Ahmad, Suhail and Meis, Jacques F and Parker, Josie E and Alfouzan, Wadha},
  title = {Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B},
  journal = {Journal of Fungi},
  year = {2025},
  volume = {11},
  number = {8},
  pages = {570},
  doi = {10.3390/jof11080570}
}
Kostenlos starten →